At an event on Friday 30th April, Regional Development Australia (RDA) Hunter released Medical Technologies and Pharmaceuticals: A Growth Sector for Hunter Central Coast to an audience of 50 industry, business, government, heath, education and research representatives.

The publication, developed in collaboration with the Hunter Central Coast (HCC) Medical Technologies & Pharmaceuticals (MTP) industry base, research & education organisations and sector experts, highlights new facts and statistics about the capability of the region’s MTP industry base and promotes the importance of the sector for the Hunter Central Coast’s future. It pinpoints opportunities for industry/research/health sector collaboration which will lead to industry and jobs growth.

This blueprint for future industries in the region incorporates the results of a recent capability audit of the Hunter Central Coast MTP sector and presents the case for the region as a viable MTP precinct.

MTP: A Growth Sector for HCC has been developed by the MedTeCCH initiative – a partnership between RDA Hunter and Ai Group (Hunter office). It will be used to engage with State and Federal bodies and decision-makers to build awareness of the Hunter Central Coast’s capabilities, improve industry engagement and encourage industry growth.

Parliamentary Secretary to the Premier, The Hon Gabrielle Upton MP commended RDA Hunter, Ai Group and local MTP companies for taking the initiative in forming MedTeCCH, saying it was a great example of industry, research and government collaborating to create more jobs, services and products.

“The NSW Government’s Turning Ideas into Jobs Accelerating R&D Action Plan supports these kinds of collaborations between sectors in NSW’s innovation ecosystem.

“It is especially gratifying to see the Central Coast Hunter precinct draw on its industry strengths to positively contribute as a hub for research commercialisation and as an investment location,” Ms Upton said.

Available on-line NOW at:

Key findings:

Key opportunities for MTP industry and regional growth:

  1. Key MTP Precinct Tenant
  2. Digital Health – Coalition of Health and Technology Partners
  3. Clinical Trials
  4. Workforce Development – QMS + Cyber
  5. Additive Manufacturing
  6. Small batch pharmacology production for clinical trials
  7. Rapid prototyping, production and testing
  8. Research funding (e.g) ARC, Federal and State Governments

MTP: A Growth Sector for HCC was developed to underpin the activities of RDA Hunter’s MedTeCCH initiative.

To engage with MedTeCCH contact Project Director, Kate O’Mara on 0412 303 744.


The MedTech and Pharmaceuticals (MTP) industry is a sector of strength and opportunity given its propensity to deliver innovation-driven jobs growth, and build on existing medical and advanced manufacturing capability. In 2020, RDA Hunter and Ai Group formed MedTeCCH: a collaboration of Central Coast Hunter (CCH)-based MedTech and Pharma companies, national industry associations, sector specialists, and education & research organisations. MedTeCCH is strengthening and growing the region’s MTP ecosystem.

MedTeCCH is:

  1. The local voice and champion for the Hunter Central Coast MTP sector;
  2. Leading the development of a sustainable, commercially successful MTP ecosystem to create andcapitalise on research and innovation opportunities;
  3. Building direct links to end-users and investors, including local and global health systems, with support for infrastructure, skills translation and R&D acceleration.


MedTeCCH is supported by MTPConnect, AMGC, NSW Health Pathology, AmpControl, Global Edge MedTech Consulting, Jurox, Whiteley Corporation, University of Newcastle, Hunter Medical Research Institute (HMRI), JHH-IP, The Ideas Hub (CCLHD), RDA Central Coast, Genesis Research Services, Paratus Clinical, Logikal, NSW Smart Sensing Network, Bosch Manufacturing Australia and Emeritus Prof Roy Green. It now includes 50 companies and organisations across industry, research, government and education plus affiliates & supporters.